The first GLP-1 drug, Exenatide (brand name Byetta), was approved by the Food and Drug Administration in 2005 to treat type 2 diabetes
Keep portions small, avoid drinking on an empty stomach, and watch closely for nausea or low blood sugar
For many patients, symptoms ease as the body adjusts
A retrospective analysis suggested that these complications were primarily observed among participants with proliferative or preproliferative retinopathy at baseline who experienced substantial reductions in HbA1c
Under the brand name Victoza, liraglutide is FDA approved for blood sugar control in adults with Type 2 diabetes, along with diet and exercise, and to reduce the risk of MACE in adults with both Type 2 diabetes and cardiovascular disease
It also supports elastin production, which gives skin its ability to bounce back